Capricor Therapeutics (CAPR) Cash from Operations (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Cash from Operations of 29254891.0 for Q1 2026, down 354.73% year-over-year from 11484844.86 in Q1 2025, and down 24.14% quarter-over-quarter from 23566743.0 in Q4 2025.
Capricor Therapeutics (CAPR) Cash from Operations (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Cash from Operations history runs 17 years deep, the most recent figure standing at 29254891.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 354.73% year-over-year to 29254891.0; the TTM figure through Mar 2026 stood at 92632632.0 (down 105.12% YoY), while the FY2025 annual figure was 69811261.0, down 74.55% from the prior year.
- Cash from Operations for Q1 2026 stood at 29254891.0, down from 23566743.0 in the prior quarter.
- The five-year high for Cash from Operations was 24046566.0 in Q1 2022, with the low at 29254891.0 in Q1 2026.
- The 5-year median for Cash from Operations is 9417750.0 (2023), against an average of 9396576.59.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations surged 822.26% in 2022, then tumbled 407.2% in 2025.
- Capricor Therapeutics' Cash from Operations stood at 6902052.0 in 2022, then plunged by 67.98% to 11594052.0 in 2023, then slipped by 27.62% to 14796329.0 in 2024, then tumbled by 59.27% to 23566743.0 in 2025, then slipped by 24.14% to 29254891.0 in 2026.
- Business Quant data shows CAPR's Cash from Operations at 29254891.0 in Q1 2026, 23566743.0 in Q4 2025, and 19688787.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | -29.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.25 Mn |
| Mar 31, 2026 | -29.25 Mn |
| Dec 31, 2025 | -23.57 Mn |
| Dec 31, 2025 | -23.57 Mn |
| Sep 30, 2025 | -19.69 Mn |
| Sep 30, 2025 | -19.69 Mn |
| Jun 30, 2025 | -20.12 Mn |
| Jun 30, 2025 | -20.12 Mn |
| Mar 31, 2025 | -6.43 Mn |
| Mar 31, 2025 | -6.43 Mn |
| Dec 31, 2024 | -14.80 Mn |
| Dec 31, 2024 | -14.80 Mn |
| Sep 30, 2024 | -11.64 Mn |
| Sep 30, 2024 | -11.64 Mn |
| Jun 30, 2024 | -12.29 Mn |
| Jun 30, 2024 | -12.29 Mn |
| Mar 31, 2024 | -1.27 Mn |
| Mar 31, 2024 | -1.27 Mn |
| Dec 31, 2023 | -11.59 Mn |
| Dec 31, 2023 | -11.59 Mn |